Webinar: Commercialisation & regulatory strategies for women’s health technology

Date: July 24 2024 

Time: 2:00PM BST

Presented by: Robin Stephens, CEO & Co-Founder, Psephos Biomedica and Erica Kantor, Head of Women’s Health, Sagentia Innovation

Hosted by: Science and Engineering Health Technologies Alliance (SEHTA)

Register here for the webinar

Psephos and Sagentia Innovation will be discussing the challenges women’s health start-ups face when developing their commercialisation strategies, particularly when choosing a regulatory pathway.

Is it better to take a direct-to-consumer approach? Or should you pursue a regulated medical device pathway?

Join our webinar to learn how – and when – to define your regulatory strategy to ensure your next women’s health innovation is a success.

Robin Stephens and Erica Kantor will be discussing:

  • The emerging women’s health technology landscape
  • The challenges women’s health start-ups face when developing and commercialising new solutions
  • The pros and cons of the direct-to-consumer approach, vs seeking regulatory approval
  • The key considerations in developing a successful commercialisation strategy

Register for the webinar hosted by the Science and Engineering Health Technologies Alliance (SEHTA) here.

Get in touch
[pardot-form id="16364"]